Artificial urinary sphincter: recent developments and the way forward.

IF 2.1 3区医学 Q2 UROLOGY & NEPHROLOGY

Current Opinion in Urology Pub Date : 2024-11-01 Epub Date: 2024-08-14 DOI:10.1097/MOU.0000000000001212

Christine Reus, Stephanie Tran, Pierre Mozer, Louis Lenfant, Aurélien Beaugerie, Emmanuel Chartier-Kastler

{"title":"Artificial urinary sphincter: recent developments and the way forward.","authors":"Christine Reus, Stephanie Tran, Pierre Mozer, Louis Lenfant, Aurélien Beaugerie, Emmanuel Chartier-Kastler","doi":"10.1097/MOU.0000000000001212","DOIUrl":null,"url":null,"abstract":"Purpose of review: The AMS 800 has dominated the treatment of postprostatectomy urinary incontinence (PPUI) due to intrinsic sphincter deficiency (ISD) for five decades. A narrative review from June 2022 to June 2024 was conducted using 'artificial urinary sphincter' (AUS) MeSH terms in Embase. We extracted information on innovative AUS, randomized controlled trials (RCTs) or prospective studies, and systematic reviews. We evaluated the latest guidelines and consensus and analyzed current trends to discuss options for advancing AUS practices.Recent findings: Of 465 papers identified, 320 were excluded (irrelevant, duplicates, non-AUS devices, non-English, veterinary), and 145 were reviewed, with 24 selected: seven on novel AUS in development, 7 with higher-level evidence (1 RCT, 1 prospective, 4 systematic reviews, 1 nonsystematic review), and 9 retrospective relevant studies [pressure regulating balloon (PRB), revision strategies, radiotherapy history, manual dexterity/cognition, transscrotal vs. transperineal approach]. The final paper summarized current guidelines from Asia & Pacific on AUS.Summary: In the past 2 years, six novel AUS have emerged, two female RCTs are ongoing, the SATURN study published its 1-year outcomes, and four systematic reviews on female AUS were conducted. These findings enhance evidence levels and position novel AUS to challenge the Gold Standard.","PeriodicalId":11093,"journal":{"name":"Current Opinion in Urology","volume":" ","pages":"399-406"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MOU.0000000000001212","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: The AMS 800 has dominated the treatment of postprostatectomy urinary incontinence (PPUI) due to intrinsic sphincter deficiency (ISD) for five decades. A narrative review from June 2022 to June 2024 was conducted using 'artificial urinary sphincter' (AUS) MeSH terms in Embase. We extracted information on innovative AUS, randomized controlled trials (RCTs) or prospective studies, and systematic reviews. We evaluated the latest guidelines and consensus and analyzed current trends to discuss options for advancing AUS practices.

Recent findings: Of 465 papers identified, 320 were excluded (irrelevant, duplicates, non-AUS devices, non-English, veterinary), and 145 were reviewed, with 24 selected: seven on novel AUS in development, 7 with higher-level evidence (1 RCT, 1 prospective, 4 systematic reviews, 1 nonsystematic review), and 9 retrospective relevant studies [pressure regulating balloon (PRB), revision strategies, radiotherapy history, manual dexterity/cognition, transscrotal vs. transperineal approach]. The final paper summarized current guidelines from Asia & Pacific on AUS.

Summary: In the past 2 years, six novel AUS have emerged, two female RCTs are ongoing, the SATURN study published its 1-year outcomes, and four systematic reviews on female AUS were conducted. These findings enhance evidence levels and position novel AUS to challenge the Gold Standard.

查看原文本刊更多论文

人工尿道括约肌：最新发展和未来方向。

审查目的：五十年来，AMS 800 一直是治疗前列腺切除术后因内在括约肌缺陷 (ISD) 导致的尿失禁 (PPUI) 的主要方法。我们使用 Embase 中的 "人工尿道括约肌"（AUS）MeSH 词条对 2022 年 6 月至 2024 年 6 月期间的文献进行了回顾。我们提取了有关创新 AUS、随机对照试验 (RCT) 或前瞻性研究以及系统综述的信息。我们评估了最新的指南和共识，分析了当前的趋势，讨论了推进 AUS 实践的方案：在确定的 465 篇论文中，我们排除了 320 篇（不相关、重复、非 AUS 设备、非英语、兽医），并对 145 篇论文进行了审查，最终选择了 24 篇：7 篇关于正在开发的新型 AUS，7 篇具有更高级别的证据（1 篇 RCT、1 篇前瞻性研究、4 篇系统性综述、1 篇非系统性综述），以及 9 篇相关的回顾性研究 [压力调节球囊 (PRB)、翻修策略、放疗史、手动灵活性/认知、经阴茎与经会阴方法]。最后一篇论文总结了亚太地区关于 AUS 的现行指南。摘要：在过去两年中，出现了六种新型 AUS，两项女性 RCT 研究正在进行中，SATURN 研究公布了其 1 年的结果，并开展了四项关于女性 AUS 的系统综述。这些发现提高了证据水平，使新型 AUS 有能力挑战黄金标准。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Opinion in Urology 医学-泌尿学与肾脏学

CiteScore

5.00

自引率

4.00%

发文量

140

审稿时长

6-12 weeks

期刊介绍： Current Opinion in Urology delivers a broad-based perspective on the most recent and most exciting developments in urology from across the world. Published bimonthly and featuring ten key topics – including focuses on prostate cancer, bladder cancer and minimally invasive urology – the journal’s renowned team of guest editors ensure a balanced, expert assessment of the recently published literature in each respective field with insightful editorials and on-the-mark invited reviews.